Discontinued — last reported Q4 '24
ResMed Net gains (losses) on investments decreased by 3410.5% to -$10.13M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 79.4%, from -$5.65M to -$10.13M. Over 2 years (FY 2022 to FY 2025), Net gains (losses) on investments shows an upward trend with a -8.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Positive values indicate successful investment management, while negative values reflect market volatility or poor asset performance.
This captures the non-cash gains or losses realized from the sale or revaluation of equity investments and securities. I...
Common for large corporations with diversified portfolios or strategic minority stakes.
gain_loss_on_investments| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.61M | -$4.40M | -$1.74M | -$11.68M | -$3.28M | $8.37M | $6.42M | -$602.00K | -$1.89M | $13.92M | -$15.47M | -$680.00K | -$1.44M | -$5.65M | -$2.53M | -$6.19M | $306.00K | -$10.13M |
| QoQ Change | — | -178.5% | +60.6% | -572.9% | +71.9% | +355.1% | -23.3% | -109.4% | -213.8% | +836.9% | -211.2% | +95.6% | -111.6% | -292.4% | +55.1% | -144.3% | +104.9% | <-999% |
| YoY Change | — | — | — | — | -158.4% | +290.0% | +469.9% | +81.6% | -122.6% | +116.9% | — | -13.0% | +23.8% | -140.6% | +83.6% | -810.3% | +121.3% | -79.4% |